Attralus Attralus is a company that develops immunotherapies and an imaging diagnostic platform designed for multiple systemic amyloid disease treatment. | ![]() Xemed Xemed is a diagnostic drug company focused on hyperpolarized gas magnetic resonance imaging technology. | ![]() Diagnostic Healthcare Diagnostic Healthcare is a company that offers medical diagnostic imaging services. | ![]() Feng Chi Biotech Feng Chi Biotech (豐技生物科技股份) is a company that distributes genetic testing technologies. | ||
Founding Date | Founding Date 2019 | Founding Date 2004 | Founding Date 2004 | Founding Date 2001 | Founding Date 2020 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Durham, US HQ | Locations Wythenshawe, GB HQ | Locations TW HQ | Locations HQ |
Employees | Employees N/A | Employees 8 | Employees 2041% increase | Employees 32 | Employees N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) NT$171.1m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods NT$84.7m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit NT$86.9m (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income NT$16.6m (FY, 2024) | Net income ($1.5m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 25m | Total funding raised N/A | Total funding raised $ 1.5m | Total funding raised N/A | Total funding raised N/A |

Xemed is a diagnostic drug company focused on hyperpolarized gas magnetic resonance imaging technology.
View company
Diagnostic Healthcare is a company that offers medical diagnostic imaging services.
View company
Feng Chi Biotech (豐技生物科技股份) is a company that distributes genetic testing technologies.
View company